Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Beth Israel Deaconess Medical Center
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Beth Israel Deaconess Medical Center (12)
2022
2021
-
Motixafortide and pembrolizumab combined to nanoliposomal irinotecan, fluorouracil, and folinic acid in metastatic pancreatic cancer: The COMBAT/ KEYNOTE-202 trial
Clinical Cancer Research, Vol. 27, Núm. 18, pp. 5020-5027
2020
-
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Nature Medicine, Vol. 26, Núm. 6, pp. 878-885
2017
-
Results from an integrated safety analysis of urelumab, an agonist anti-CD137 monoclonal antibody
Clinical Cancer Research, Vol. 23, Núm. 8, pp. 1929-1936
2011
-
Conclusions and Future Possibilities: IORT
INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION
-
Defining the critical hurdles in cancer immunotherapy
Journal of Translational Medicine
-
IORT with Electron-Beam, High-Dose-Rate Brachytherapy or Low-KV/Electronic Brachytherapy: Methodological Comparisons
INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION (HUMANA PRESS INC), pp. 99-115
-
Rationale and Historical Perspective of Intraoperative Irradiation
INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION (HUMANA PRESS INC), pp. 3-26
-
Recurrent Colorectal Cancer
INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION (HUMANA PRESS INC), pp. 323-351
-
Retroperitoneal Sarcomas
INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION (HUMANA PRESS INC), pp. 353-386
2009
-
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
Nature, Vol. 458, Núm. 7235, pp. 223-227
-
The research mission in myeloma
Leukemia